SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-170838
Filing Date
2021-05-24
Accepted
2021-05-24 16:05:36
Documents
12
Period of Report
2021-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d188644d8k.htm   iXBRL 8-K 27989
  Complete submission text file 0001193125-21-170838.txt   154103

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krys-20210521.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210521_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210521_pre.xml EX-101.PRE 11876
5 EXTRACTED XBRL INSTANCE DOCUMENT d188644d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 21954847
SIC: 2836 Biological Products, (No Diagnostic Substances)